Monday, March 17, 2025 | 09:17 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals

On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals

Lyka Labs
Premium

Lyka Labs

SI Reporter Mumbai
Shares of Lyka Labs were locked at the upper circuit for the second straight day, up 5 per cent at Rs 129.15, also its 52-week high on the BSE on Tuesday, after Ipca Laboratories bought 1 million shares of pharmaceuticals company via open market deals.

On Monday, November 23, 2021, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals, the exchange data reveals.

Vipul Priyakant Dalal (240,121 shares) and Shreyans Jashwantlal Shah (345,000 shares) have sold the company’s shares

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in